Duininck Troy M, van Heerden Jon A, Fatourechi Vahab, Curlee Kathleen J, Farley David R, Thompson Geoffrey B, Grant Clive S, Lloyd Ricardo V
Division of Gastroenterologic and General Surgery, Mayo Clinic Rochester, Rochester, Minnesota 55905, USA.
Endocr Pract. 2002 Jul-Aug;8(4):255-8. doi: 10.4158/EP.8.4.255.
To review a 35-year experience with management of de Quervain's thyroiditis (dQT), an uncommon inflammatory process of the thyroid gland that is usually treated medically and seldom necessitates surgical intervention.
A retrospective review was performed of medical records of patients with dQT treated surgically at a single institution between 1966 and 2000. The study group consisted of 11 women and 6 men (mean age, 50 years; range, 23 to 66). All pathology specimens were reviewed.
Of the 17 study patients, 14 had surgical treatment before 1980. Typical symptoms of dQT, including pain and tenderness of the thyroid gland, occurred in eight patients, and two had dysphagia from an enlarged thyroid gland. Seven patients were asymptomatic. The indications for operation were a clinically indeterminate thyroid nodule (N = 14), dysphagia (N = 2), and hyperthyroidism with nodular goiter (N = 1). Fine-needle aspiration biopsy (FNAB) was performed in only two patients; biopsy findings were suspicious for a malignant lesion in one patient, and nondiagnostic in the other patient. Thyroid function tests (N = 14) revealed that 12 patients were euthyroid and 2 had hyperthyroidism. Surgical treatment consisted of unilateral lobectomy in 4 patients, near-total thyroidectomy in 12, and total thyroidectomy in 1. Temporary vocal cord palsy and temporary hypocalcemia occurred in one patient each. Fourteen patients (mean follow-up, 204 months) required long-term thyroid replacement therapy. No patient required further thyroid surgical intervention or had further thyroid disease.
Although surgical intervention is not the primary treatment for dQT, when resection is performed it can be done safely and with low associated morbidity. In the modern era, with routine use of FNAB, fewer patients with this rare entity will require surgical exploration. Patients with atypical features and ones with euthyroidism are more likely candidates than others for surgical intervention.
回顾35年来对亚急性甲状腺炎(dQT)的治疗经验,亚急性甲状腺炎是一种罕见的甲状腺炎症性疾病,通常采用内科治疗,很少需要手术干预。
对1966年至2000年间在单一机构接受手术治疗的dQT患者的病历进行回顾性研究。研究组包括11名女性和6名男性(平均年龄50岁;范围23至66岁)。所有病理标本均进行了复查。
17例研究患者中,14例在1980年前接受了手术治疗。8例患者出现了dQT的典型症状,包括甲状腺疼痛和压痛,2例因甲状腺肿大出现吞咽困难。7例患者无症状。手术指征为临床无法确定的甲状腺结节(N = 14)、吞咽困难(N = 2)和结节性甲状腺肿伴甲状腺功能亢进(N = 1)。仅2例患者进行了细针穿刺活检(FNAB);1例患者的活检结果怀疑为恶性病变,另1例患者的活检结果无诊断意义。甲状腺功能检查(N = 14)显示,12例患者甲状腺功能正常,2例患者甲状腺功能亢进。手术治疗包括4例行单侧甲状腺叶切除术,12例行近全甲状腺切除术,1例行全甲状腺切除术。1例患者出现暂时性声带麻痹,1例患者出现暂时性低钙血症。14例患者(平均随访204个月)需要长期甲状腺替代治疗。没有患者需要进一步的甲状腺手术干预或出现进一步的甲状腺疾病。
虽然手术干预不是dQT的主要治疗方法,但在进行切除时可以安全进行,且相关发病率较低。在现代,随着FNAB的常规使用,这种罕见疾病需要手术探查的患者将会减少。具有非典型特征的患者和甲状腺功能正常的患者比其他患者更有可能成为手术干预的对象。